Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Viking (NYSE: VIK) was founded in 1997 and provides destination-focused journeys on rivers, oceans and lakes around the world. Designed for curious travelers with interests in science, history, culture and cuisine, Chairman and CEO Torstein Hagen
Analytical Project Leader (Scientist / Senior Scientist) (m/f/d) Freelance/Contracting project Basel Stadt Start date: asap Reference number: /1 Diesen Job teilen oder drucken Responsibilities Developing a phase-appropriate control strategy for drug substances and drug products Collaborating
Revolution Medicines is a late‑stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Manager: Global Membership Communications, IBBY Programmes, & Strategic Advocacy Department: International Board on Books for Young People Secretariat. Location: Basel, Switzerland (100%, In-Office). Strategic Mandate: To increase IBBY’s global advocacy and operational capabilities by leveraging deep